BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Eisai Co., Ltd. Expands Venture Investment to Accelerate Drug Discovery Innovation

Eisai Co., Ltd. announced that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim of disc...

June 04, 2024 | News

Telix Pharmaceuticals Completes BLA Submission to FDA for Breakthrough Kidney Cancer Imaging Agent TLX250-CDx

Telix Pharmaceuticals announces that it has completed the submission of a Biologics License Application (BLA) to the United States (U.S.) Food an...

June 03, 2024 | News

LumaCina to Produce Oral Morphine Amidst Critical Shortage in New Zealand

LumaCina, the pharmaceutical supplier and marketing division of Bridgewest Perth Pharma announce new production of Oral Morphine to meet cr...

May 31, 2024 | News

Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone

Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...

May 31, 2024 | News

Enzene Biosciences Launches New Drug Discovery Division, Expands CDMO Services Amid Growing Biotech Demands

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (EnzeneXTM) today announces the launch o...

May 30, 2024 | News

Metabolon Enhances Metabolomics Services with New Spectral Data Option

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

May 29, 2024 | News

Providence Therapeutic Holdings and Ontario Institute for Cancer Research Announce Landmark Collaboration for mRNA Drug Discovery and Development

Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines ...

May 24, 2024 | News

CAS Unveils CAS BioFinder Discovery Platform™ to Transform Drug Discovery Process

CAS, a division of the American Chemical Society specializing in scientific knowledge management, announced the launch of the CAS BioFinder Discovery Platf...

May 22, 2024 | News

Ractigen Therapeutics' saRNA Drug RAG-01 Receives Fast Track Designation from FDA

Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been g...

May 22, 2024 | News

NUS Scientists Discover Novel Method to Activate Muscle Cells’ Natural Defences Against Cancer Using Magnetic Pulses

A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) ...

May 22, 2024 | News

BeiGene and Glenmark Forge Strategic Partnership to Distribute Innovative Cancer Treatments in India

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new partnership with Glenmark Specialty S.A. (Glen...

May 21, 2024 | News

Innovent Biologics' New Drug for Thyroid Eye Disease Granted Priority Review in China

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...

May 21, 2024 | News

EFECON® Becomes First Approved Therapy for IgAN in China, Offering Hope to Millions with Improved Patient Care and Disease Management

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines ...

May 15, 2024 | News

Eisai's Antiepileptic Drug Fycompa® Gains Approval in China for Additional Indication

Eisai Co., Ltd. announced that it has received approval in China for the additional indication of its in-house discovered antiepileptic drug (AED) Fycompa&...

May 14, 2024 | News

Stay Connected